Trials / Unknown
UnknownNCT02238093
Cardiorenal Syndrome in End-Stage Kidney Disease
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 270 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality. The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.
Conditions
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-09-12
- Last updated
- 2014-09-12
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02238093. Inclusion in this directory is not an endorsement.